Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

EVALUATION OF 30-DAY MORTALITY AFTER A VISIT TO THE LAPEYRONIE ADULT EMERGENCY DEPARTMENT OF THE CHU MONTPELLIER FOR SEPSIS OR SEPTIC SHOCK

NCT05140213 is registered in ClinicalTrials.gov with University Hospital, Montpellier as lead sponsor.

NCT NCT05140213
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05140213 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
EVALUATION OF 30-DAY MORTALITY AFTER A VISIT TO THE LAPEYRONIE ADULT EMERGENCY DEPARTMENT OF THE CHU MONTPELLIER FOR SEPSIS OR SEPTIC SHOCK
Lead sponsor
University Hospital, Montpellier
Phase
Observational
Overall status
Completed
Start date
December 12, 2020
Completion date
August 30, 2021
Enrollment
371 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

sepsis, septic shock